In the subcohorts of patients with a diagnosis of bipolar disorder, continuing lithium was associated with decreased end-stage CKD, whereas continuing anticonvulsants was not.<div><a href="http://www.renalandurologynews.com/end-stage-renal-disease-lithium-therapy-does-not-increase-risk/article/708655/" target="_blank">Original link</a></div>